The Latest in Bleeding Disorders

IV bevacizumab improves severe bleeding in HHT

January 31, 2018

CHMP recommends approval of emicizumab

January 27, 2018

Bleeding Disorders

Low inhibitor rate observed in PUPs with hemophilia A

January 24, 2018

EC approves product to treat hemophilia A

January 17, 2018

Emicizumab still available despite legal issues

January 14, 2018

Update of gene therapy in hemophilia A

January 9, 2018

Caplacizumab improves outcomes in aTTP

January 5, 2018

FDA lifts clinical hold on fitusiran trials

December 19, 2017

Emicizumab reduces bleeds in kids with hemophilia A and inhibitors

December 11, 2017

Gene therapy seems safe, effective in hemophilia B

December 7, 2017

FDA grants priority review to NDA for avatrombopag

November 29, 2017

Product approved to treat patients with hemophilia A and inhibitors

November 17, 2017

CHMP backs therapy for hemophilia A

November 14, 2017

CHMP recommends approval of romiplostim in kids

November 12, 2017

Drug receives orphan designation for treatment of PNH

November 9, 2017